Collectively, we proposed a TFCR-based framework to screen for key genes in bladder cancer, and revealed that CLIC3 could be a regulatory factor of NAT10-catalyzed ac4C modification, elucidating a novel mechanism for mRNA ac4C modification. The gene discussed is NAT10; the disease is urinary bladder cancer.